| Gabrielle Genevieve Santarelli, DO | |
|
1991 Sproul Rd, Broomall, PA 19008-3512 | |
| (610) 325-0309 | |
| Not Available |
| Full Name | Gabrielle Genevieve Santarelli |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 10 Years |
| Location | 1991 Sproul Rd, Broomall, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467870238 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | OS018801 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Main Line Health Home Care & Hospice - Home Health | Radnor, PA | Home health agency |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Healthcare | 1951215201 | 894 |
News Archive
Most patients who survived severe acute respiratory syndrome (SARS) had good physical recovery, but they or their caregivers often reported a decline in mental health one year later, according to a study in the June 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
The Whittemore Peterson Institute for Neuro-Immune Disease (WPI) and Cerus Corporation announced positive results from a study demonstrating the efficacy of the INTERCEPT Blood System to inactivate XMRV, a human retrovirus, in donated platelet components.
Two-thirds (69%) of U.S. primary care physicians reported using electronic medical records (EMRs) in 2012, up from less than half (46%) in 2009, according to findings from the 2012 Commonwealth Fund International Health Policy Survey, published as a Web First online today in the journal Health Affairs. Primary care physicians in the U.S.-the only country in the study without universal health coverage-stand out in the survey for reporting that their patients often cannot afford care (59%).
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, today presented results of preclinical studies on its novel Phosphoinositide 3-kinase alpha inhibitor at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida.
A potentially revolutionary new technology - that could saves thousands of lives in Intensive Care Units around the world - is being trialled in a UK study co-led by Queen's University Belfast.
› Verified 3 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
Most patients who survived severe acute respiratory syndrome (SARS) had good physical recovery, but they or their caregivers often reported a decline in mental health one year later, according to a study in the June 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
The Whittemore Peterson Institute for Neuro-Immune Disease (WPI) and Cerus Corporation announced positive results from a study demonstrating the efficacy of the INTERCEPT Blood System to inactivate XMRV, a human retrovirus, in donated platelet components.
Two-thirds (69%) of U.S. primary care physicians reported using electronic medical records (EMRs) in 2012, up from less than half (46%) in 2009, according to findings from the 2012 Commonwealth Fund International Health Policy Survey, published as a Web First online today in the journal Health Affairs. Primary care physicians in the U.S.-the only country in the study without universal health coverage-stand out in the survey for reporting that their patients often cannot afford care (59%).
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, today presented results of preclinical studies on its novel Phosphoinositide 3-kinase alpha inhibitor at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida.
A potentially revolutionary new technology - that could saves thousands of lives in Intensive Care Units around the world - is being trialled in a UK study co-led by Queen's University Belfast.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gabrielle Genevieve Santarelli, DO 1991 Sproul Road, Suit 625, Broomall, PA 19008 Ph: (610) 325-0309 | Gabrielle Genevieve Santarelli, DO 1991 Sproul Rd, Broomall, PA 19008-3512 Ph: (610) 325-0309 |
News Archive
Most patients who survived severe acute respiratory syndrome (SARS) had good physical recovery, but they or their caregivers often reported a decline in mental health one year later, according to a study in the June 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
The Whittemore Peterson Institute for Neuro-Immune Disease (WPI) and Cerus Corporation announced positive results from a study demonstrating the efficacy of the INTERCEPT Blood System to inactivate XMRV, a human retrovirus, in donated platelet components.
Two-thirds (69%) of U.S. primary care physicians reported using electronic medical records (EMRs) in 2012, up from less than half (46%) in 2009, according to findings from the 2012 Commonwealth Fund International Health Policy Survey, published as a Web First online today in the journal Health Affairs. Primary care physicians in the U.S.-the only country in the study without universal health coverage-stand out in the survey for reporting that their patients often cannot afford care (59%).
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, today presented results of preclinical studies on its novel Phosphoinositide 3-kinase alpha inhibitor at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida.
A potentially revolutionary new technology - that could saves thousands of lives in Intensive Care Units around the world - is being trialled in a UK study co-led by Queen's University Belfast.
› Verified 3 days ago
Dr. Julian L Gladstone, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1999 Sproul Rd, Ste 21, Broomall, PA 19008 Phone: 610-353-6400 Fax: 610-356-1836 | |
John D Sprandio, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Lawrence Rd, Suite 201, Broomall, PA 19008 Phone: 610-492-5900 Fax: 610-492-5810 | |
Walter Kornienko, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Lawrence Rd Ste 800, Broomall, PA 19008 Phone: 610-848-7000 Fax: 610-325-2016 | |
Dr. Larry M Shrager, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Sproul Rd Suite 100, Marple Commons, Broomall, PA 19008 Phone: 610-353-3500 Fax: 610-353-2015 | |
Dr. Margaret Elaine Walker, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2000 Sproul Rd, Suite 300, Broomall, PA 19008 Phone: 610-359-1355 Fax: 610-359-9228 | |
Dr. Laura Kathryn Gallo, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1991 Sproul Rd Ste 625, Broomall, PA 19008 Phone: 610-325-0309 Fax: 610-325-0459 | |
Stephen A Shore, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Lawrence Rd, Suite 201, Broomall, PA 19008 Phone: 610-492-5900 Fax: 610-492-5903 |